What is the monoamine hypothesis of depression?
Master all 18 flashcards
By mastering this deck, you'll gain a comprehensive understanding of how various neurochemical systems influence behavior and mental health, enabling you to better interpret research findings, clinical symptoms, and pharmacological interventions in psychology and psychiatry.
Showing 18 of 18 cards
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the monoamine hypothesis of depression? |
Master all 18 flashcards
Explore other decks you might find helpful
Compare the monoamine hypothesis, HPA axis model, and other frameworks explaining how chemicals influence mental processes.
| Think monoamines = mood regulators |
| 2 | How does the HPA axis model explain stress-related behavior and mood disorders? | The HPA axis model suggests that chronic stress activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to elevated cortisol levels, which can impair brain function and contribute to depression and anxiety. | HPA = stress response system |
| 3 | What role do neurotransmitters play in the monoamine hypothesis? | Neurotransmitters like serotonin, norepinephrine, and dopamine are central to this hypothesis; their decreased activity or levels are linked to depressive symptoms. | Monoamines = mood and motivation |
| 4 | In what way does the HPA axis influence neurochemical regulation of behavior? | Activation of the HPA axis leads to cortisol release, which can alter neurotransmitter systems (e.g., serotonin and dopamine) and brain structures involved in mood and stress regulation. | Stress hormones affect brain chemistry |
| 5 | Name one limitation of the monoamine hypothesis. | It oversimplifies depression by focusing solely on neurotransmitter levels, ignoring other factors like neuroplasticity and hormonal influences. | Not just chemicals |
| 6 | What is the primary function of cortisol in the context of neurochemical regulation? | Cortisol helps regulate stress responses but, when chronically elevated, can impair neurotransmitter function and neuroplasticity, influencing mood and behavior. | Stress hormone |
| 7 | How does the HPA axis interact with the serotonin system in mood regulation? | Elevated cortisol from HPA axis activation can decrease serotonin levels and receptor sensitivity, contributing to depressive symptoms. | Stress impacts mood chemicals |
| 8 | Which neurochemical system is most directly associated with reward and motivation, often discussed in models of behavior? | The dopamine system, particularly the mesolimbic pathway, is most associated with reward processing and motivation. | Dopamine = drive and pleasure |
| 9 | Compare the monoamine hypothesis and the HPA axis model in terms of their primary focus. | The monoamine hypothesis centers on neurotransmitter imbalances affecting mood directly, while the HPA axis model emphasizes hormonal responses to stress that influence brain chemistry and behavior. | Neurotransmitters vs. stress hormones |
| 10 | What is a practical example of how the monoamine hypothesis influences treatment for depression? | Selective serotonin reuptake inhibitors (SSRIs), which increase serotonin levels, are commonly prescribed based on this hypothesis. | Think Prozac |
| 11 | Why is it important to consider both the monoamine hypothesis and the HPA axis model when understanding depression? | Because depression is multifaceted; neurotransmitter imbalances and hormonal dysregulation often coexist, influencing symptoms and treatment response. | Holistic view |
| 12 | What is neuroplasticity, and how might it relate to neurochemical regulation models? | Neuroplasticity refers to the brain's ability to change and adapt; neurochemical systems like serotonin and cortisol influence neuroplasticity, affecting behavior and mental health. | Brain's adaptability |
| 13 | How do pharmacological treatments targeting monoamines support the monoamine hypothesis? | Medications like SSRIs and SNRIs increase monoamine levels, which can alleviate depressive symptoms, supporting the idea that monoamine deficits contribute to depression. | Increase mood chemicals |
| 14 | What is one biological marker associated with HPA axis dysregulation in mood disorders? | Elevated cortisol levels, especially in the evening or in response to stress, are often observed in individuals with depression and anxiety disorders. | High stress hormone |
| 15 | How might chronic stress influence neurotransmitter systems according to the HPA axis model? | Chronic stress can lead to sustained cortisol elevation, which may reduce serotonin and dopamine activity, impair neurogenesis, and contribute to mood disorders. | Stress wears down brain chemistry |
| 16 | What is an example of a treatment approach based on the HPA axis model? | Stress reduction techniques, such as mindfulness and cognitive-behavioral therapy, aim to regulate HPA axis activity and lower cortisol levels. | Stress management |
| 17 | How do the monoamine hypothesis and HPA axis model complement each other in explaining behavior? | They offer different but interconnected perspectives: monoamine imbalance affects mood directly, while HPA axis dysregulation influences neurochemical systems and stress responses that impact mood. | Multiple pathways to mood |
| 18 | What is a key limitation common to both the monoamine hypothesis and the HPA axis model? | They do not fully account for individual differences, neuroplasticity, or environmental factors that also influence behavior and mental health. | Simplified models |